Biochemical markers of bone metabolism in animals: uses and limitations

Routine assessment of the skeleton's response to disease and injury traditionally has consisted of plain-film radiography supplemented with advanced imaging techniques, such as computed tomography, magnetic resonance imaging, nuclear scintigraphy, and bone densitometry. Although these techniques provide increased sensitivity as compared with radiography, they still are limited by the fact that they can only document the net results of past skeletal activity. In contrast, serum and urinary biomarkers of bone formation and resorption provide near real-time information about bone cell activity. In this review, I describe the scientific rationale behind the use of these markers in humans and detail the efforts that have been made to adapt this technology to veterinary medicine and animal research. Commercial assay kits that are applicable to different animal species are described, and the potential limitations of the technology are discussed. The goal of this review is to provide clinical pathologists and researchers with the information needed to decide whether the use of bone markers is likely to be helpful and to select the most appropriate marker (or panel of markers) to answer a particular question.     

Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy

BACKGROUND: Dilated cardiomyopathy (DCM) results in progressive myocardial and circulatory dysfunction causing activation of a number of neurohormonal systems, including the endothelin (ET) system, which is only beginning to be described in clinical veterinary medicine. Measurement of these circulating neurohormones possesses potential utility in the diagnosis, staging, and assessment of prognosis in cardiac disease. HYPOTHESIS: We hypothesized that plasma big ET-1, norepinephrine (NE), aldosterone, and atrial natriuretic peptide (ANP) concentrations in normal Dobermans would differ from those in Dobermans with DCM, and that concentrations of these hormones would be associated with time to congestive heart failure (CHF) or death. ANIMALS: Thirty client-owned Dobermans (10 each of normal, occult DCM, and overt DCM) were included in the study. METHODS: Dogs underwent an echocardiogram, ECG, and blood sample collection. Neurohormones were measured by high-pressure liquid chromatography (NE) or commercial assays. RESULTS: Dogs with occult DCM had significantly higher ANP concentrations compared with normal dogs (least squares means [95% confidence interval, CI]: occult female 53.7 pg/mL [40.2-71.7] versus normal female 31.6 pg/mL [24.8-40.3], P = .026; occult male 86.1 pg/mL [64.7-115] versus normal male 12.1 pg/mL [5.1-28.7], P = .011). Dogs with overt DCM had significantly higher concentrations of all neurohormones compared with the normal group. Furthermore, increasing big ET-1 (risk ratio [RR] 2.7, CI 1.3-8.6, P = .01) and NE concentrations (RR 3.9, CI 1.1-18.1, P = .03) over 1 month were associated with a shorter survival time. CONCLUSIONS AND CLINICAL IMPORTANCE: High ANP concentrations can identify dogs with advanced occult DCM. Increasing big ET-1 or NE concentrations over time can be useful predictors of poor prognosis.     

Relationships Among Plasma Proteins,Hematological Values,and Gender in Thoroughbred and Miniature Horses

Our objective was to investigate the relationships among plasma proteins, hematological values, and gender in Thoroughbred (nine females and 16 males) and miniature (30 females and four males) horses. Twenty-two protein bands, ranging from 8 to 264 kDa, were detected in horse plasma. Red blood cells, hemoglobin, and hematocrit were negatively correlated (r ≤ −0.29; P < .05) with bands 13 and 17 but positively correlated (r ≥ 0.40; P < .01) with band 3. A negative correlation (r ≤ −0.27; P < .05) was detected between bands 1, 8, and lymphocytes. Neutrophils were positively correlated with bands 1 and 8. Basophils had a positive correlation (r = 0.36) with band 12 and negative correlation with bands 11 (r = −0.30) and 13 (r = −0.48). Platelets had positive correlations (r ≥ 0.24; P < .10) with bands 3, 4, 5, 10, 14, 19, and 22. The relative intensities of protein bands 4, 16, and 22 were affected (P < .05) by an interaction of breed and gender. Gender effects (P < .05) were detected for plasma protein bands 1 (1.6 vs. 2.4 ± 0.23), 5 (2.6 vs. 3.6 ± 0.25), and 11 (8.7 vs. 13.2 ± 1.1), respectively, for females and males. Breed effects (P < .05) were detected for plasma protein bands 5 (2.5 vs. 3.8 ± 0.25) and 11 (9.0 vs. 12.9 ± 1.1), respectively, for Thoroughbreds and miniatures. When developing new pathophysiological tools for equine disease diagnosis and therapy, breed and gender effects should be considered.     

土壤微生物影响土壤健康的作用机制研究进展

土壤健康是农业可持续发展的中心主题。土壤微生物参与土壤生态功能、环境功能和免疫功能协同驱动土壤生命系统运转，是维持土壤健康的核心与关键。了解不同微生物介导的土壤健康调控机制对有效利用这些核心微生物维持和改善土壤健康至关重要。本文围绕微生物参与调节土壤碳循环、养分循环，改变土壤结构、抑制植物病虫害、污染控制等主要生物过程系统梳理了微生物在调控土壤健康中的重要作用，以及微生物作为土壤健康的敏感指标对土壤健康的指示与预警作用。强调未来应加强驱动土壤健康特定功能以及多个生物过程的核心微生物组信息数据库挖掘、构建与生产应用研究，为定向利用微生物改善农业土壤生态系统功能、维持土壤健康以及保障土壤可持续发展提供科学依据。